IPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innate Pharma SA

Watchlist Manager

Watchlist

Price: 1.48 USD 3.5% Market Closed

Market Cap: $119.8m

	Innate Pharma SA NASDAQ:IPHA	FR
	Korshunovskiy GOK PAO MOEX:KOGK	RU
M	McFarlane Lake Mining Ltd NEO:MLM	CA
C	Costco Wholesale Corp BMV:COST	US
C	Chow Steel Industries PCL SET:CHOW	TH

Profitability Summary

Innate Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

93% > 48%

Negative Operating Margin

-1 125%

Negative 3Y Average Operating Margin

-732%

Declining Operating Margin

-152% > -1 125%

Negative Net Margin

-1 122%

Negative 3Y Average Net Margin

-700%

Declining Net Margin

-144% > -1 122%

Negative Free Cash Flow Margin

-1 012%

Negative 3Y Average Free Cash Flow Margin

-635%

Declining Free Cash Flow Margin

-74% > -1 012%

Exceptional ROE

268%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-257%

Declining ROIC

-55% > -274%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.